Yahoo Suche Web Suche

Suchergebnisse

1. Suchergebnisse:

1. www.businessinsider.de › wissenschaft › gesundheitModerna: Die häufigsten Nebenwirkungen des Corona-Impfstoffs

   www.businessinsider.de › wissenschaft › gesundheit

   • Im Cache

   9. Jan. 2021 · Dies sind die häufigsten Nebenwirkungen beim Corona-Impfstoff von Moderna. Neun von zehn Personen, die sich mit dem Corona -Vakzin von Moderna impfen ließen, hatten von Nebenwirkungen berichtet. Die häufigsten Nebenwirkungen waren Schmerzen an der Injektionsstelle, Müdigkeit, Kopfschmerzen, Muskel- und Gelenkschmerzen sowie Schüttelfrost.

2. www.who.int › news-room › feature-storiesThe Moderna COVID-19 (mRNA-1273) vaccine: what you need to know

   www.who.int › news-room › feature-stories

   • Im Cache

   18. Aug. 2022 · The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued updated interim recommendations for the use of the Moderna COVID-19 (mRNA-1273) vaccine against COVID-19. This article provides a summary of those interim recommendations; you may access the full guidance document here. Here is what you need to know.

3. www.modernatx.com › power-of-mrnaScience of mRNA - Moderna

   www.modernatx.com › power-of-mrna

   • Im Cache

   Scientists design each mRNA to give cells directions to make a particular protein. 1. Making an mRNA medicine. To protect the mRNA and help deliver it into cells, the mRNA is wrapped with lipids, or fats. 2. Deliver mRNA into the body. mRNA vaccines are given as an injection. Future mRNA treatments might be delivered by an infusion.

4. www.ema.europa.eu › en › medicinesSpikevax (previously COVID-19 Vaccine Moderna)

   www.ema.europa.eu › en › medicines

   • Im Cache

   6. Jan. 2021 · Spikevax is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people from the age of 6 months. The originally authorised Spikevax contains elasomeran, a molecule called messenger RNA (mRNA) with instructions for producing a protein from the original strain of SARS-CoV-2, the virus that causes COVID-19.

5. news.modernatx.com › news › news-detailsModerna Receives U.S. FDA Approval for Updated COVID-19 Vaccine

   news.modernatx.com › news › news-details

   • Im Cache

   11. Sept. 2023 · In June 2023, the U.S. FDA advised that COVID-19 vaccines should be updated to a monovalent XBB.1.5 composition for the 2023 - 2024 vaccination season. At the June VRBPAC, Moderna presented clinical data showing that its updated vaccine resulted in robust immune responses across multiple XBB sublineages, including XBB.1.5 and XBB.1.16.

6. www.modernatx.com › es-ESPioneering mRNA technology - Moderna

   www.modernatx.com › es-ES

   • Im Cache

   Moderna inaugura en Madrid el Centro Internacional de Excelencia Analítica de Europa Ubicado en el edificio OMinfinito, la nueva sede de Moderna en Madrid y Centro Internacional de Excelencia Analítica de Europa reforzará las capacidades operativas internacionales y relaciones regulatorias de Moderna en toda la Unión Europea.

7. news.modernatx.com › news › news-detailsModerna Achieves Positive Interim Results from Phase 3 Trial of...

   news.modernatx.com › news › news-details

   • Im Cache

   26. März 2024 · CAMBRIDGE, MA / ACCESSWIRE / March 26, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1283, the Company's next-generation COVID-19 vaccine, has successfully met the primary endpoints of its Phase 3 clinical trial, demonstrating a higher immune response against SARS-CoV-2 when compared to mRNA-1273.222, Moderna's licensed COVID-19 ...